About Immunic (IMUX)
Immunic, Inc., formerly Vital Therapies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The Company is developing three small... Read more
- USD0.72
- USD0.74
- USD0.70
- USD2.11
- -22.80%
- --
- 1.25M
- 3.39M
- 69M
- 0.56
- -35.60%
Stock News
5 hours ago
OpenWay and ACB Power a New Era of Cardholder Choice with Southeast Asia's First Visa Flex Launch
Yahoo
6 hours ago
Worthington Enterprises: Fully Valued After A Impressive Move
SeekingAlpha
6 hours ago
Lithia Motors: Earnings Back On The Growth Track
SeekingAlpha
yesterday
Jim Cramer lists five market sectors he thinks are working right now and five that are not
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
